Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.275 SGD | +1.85% | -.--% | -3.51% |
Valuation
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 63.09 | 94.64 | 92.63 | 103.4 | 88.12 | 84.9 | - | - |
Enterprise Value (EV) 1 | 63.09 | 94.64 | 92.63 | 103.4 | 88.12 | 84.9 | 84.9 | 84.9 |
P/E ratio | 9.68 x | 15.4 x | 13.2 x | 9.15 x | 10.3 x | 7.65 x | 7.08 x | 7.05 x |
Yield | 4.76% | 1.97% | 2.23% | 3.31% | 15.6% | 3.85% | 4.05% | 4.36% |
Capitalization / Revenue | 0.53 x | 0.77 x | 0.74 x | 0.64 x | 0.52 x | 0.46 x | 0.44 x | 0.43 x |
EV / Revenue | 0.53 x | 0.77 x | 0.74 x | 0.64 x | 0.52 x | 0.46 x | 0.44 x | 0.43 x |
EV / EBITDA | 6.23 x | 10.2 x | 8.78 x | 6 x | 6.46 x | 5.27 x | 5.2 x | 5.7 x |
EV / FCF | 7.05 x | 25.2 x | -10.4 x | 6.34 x | 19.8 x | 8.98 x | 9.03 x | 8.12 x |
FCF Yield | 14.2% | 3.97% | -9.59% | 15.8% | 5.04% | 11.1% | 11.1% | 12.3% |
Price to Book | 1.44 x | 2.01 x | 1.7 x | 1.5 x | 1.4 x | 1.17 x | 1.05 x | 0.98 x |
Nbr of stocks (in thousands) | 300,430 | 300,430 | 308,776 | 308,776 | 309,198 | 308,727 | - | - |
Reference price 2 | 0.2100 | 0.3150 | 0.3000 | 0.3350 | 0.2850 | 0.2750 | 0.2750 | 0.2750 |
Announcement Date | 26/02/20 | 25/02/21 | 23/02/22 | 28/02/23 | 27/02/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 119.4 | 123.7 | 125.9 | 162.3 | 170.6 | 182.8 | 191.6 | 195.6 |
EBITDA 1 | 10.13 | 9.299 | 10.56 | 17.25 | 13.64 | 16.1 | 16.33 | 14.89 |
EBIT 1 | 8.125 | 7.218 | 8.351 | 14.53 | 10.84 | 12.9 | 13.7 | 14.8 |
Operating Margin | 6.8% | 5.84% | 6.63% | 8.95% | 6.36% | 7.06% | 7.15% | 7.57% |
Earnings before Tax (EBT) 1 | 7.987 | 7.108 | 8.256 | 14.29 | 10.56 | 13.74 | 14.9 | 14.9 |
Net income 1 | 6.53 | 6.163 | 6.846 | 11.35 | 8.568 | 11.07 | 11.99 | 11.95 |
Net margin | 5.47% | 4.98% | 5.44% | 6.99% | 5.02% | 6.05% | 6.26% | 6.11% |
EPS 2 | 0.0217 | 0.0205 | 0.0227 | 0.0366 | 0.0277 | 0.0360 | 0.0388 | 0.0390 |
Free Cash Flow 1 | 8.951 | 3.759 | -8.879 | 16.32 | 4.445 | 9.45 | 9.4 | 10.46 |
FCF margin | 7.49% | 3.04% | -7.05% | 10.05% | 2.61% | 5.17% | 4.91% | 5.35% |
FCF Conversion (EBITDA) | 88.36% | 40.42% | - | 94.6% | 32.59% | 58.71% | 57.56% | 70.25% |
FCF Conversion (Net income) | 137.08% | 60.99% | - | 143.77% | 51.88% | 85.38% | 78.39% | 87.53% |
Dividend per Share 2 | 0.0100 | 0.006200 | 0.006700 | 0.0111 | 0.0446 | 0.0106 | 0.0112 | 0.0120 |
Announcement Date | 26/02/20 | 25/02/21 | 23/02/22 | 28/02/23 | 27/02/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: |
---|
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net Debt | - | - | - | - | - | - | - | - |
Net Cash position | - | - | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
Free Cash Flow 1 | 8.95 | 3.76 | -8.88 | 16.3 | 4.45 | 9.45 | 9.4 | 10.5 |
ROE (net income / shareholders' equity) | 15.7% | 13.5% | 13.4% | 18.3% | 13% | 16.2% | 15.6% | 14.4% |
ROA (Net income/ Total Assets) | 8.41% | 7.37% | 7.61% | 10.6% | 7.28% | 9.3% | 9.6% | 8.7% |
Assets 1 | 77.65 | 83.64 | 89.93 | 106.8 | 117.6 | 119 | 124.9 | 137.4 |
Book Value Per Share 2 | 0.1500 | 0.1600 | 0.1800 | 0.2200 | 0.2000 | 0.2400 | 0.2600 | 0.2800 |
Cash Flow per Share | - | - | - | - | - | - | - | - |
Capex 1 | 0.5 | 0.37 | 0.84 | 1.32 | 1.2 | 2 | 2 | 3 |
Capex / Sales | 0.42% | 0.3% | 0.66% | 0.81% | 0.7% | 1.09% | 1.04% | 1.53% |
Announcement Date | 26/02/20 | 25/02/21 | 23/02/22 | 28/02/23 | 27/02/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-3.51% | 62.25M | |
+14.53% | 69.79B | |
+7.11% | 8.2B | |
-20.55% | 7.96B | |
-5.04% | 7.91B | |
+2.32% | 4.69B | |
+17.12% | 4.32B | |
-1.24% | 3.99B | |
-3.78% | 3.81B | |
+21.42% | 3.62B |
- Stock Market
- Equities
- 1J5 Stock
- Financials Hyphens Pharma International Limited